Gene Polymorphisms Influencing Steroid Synthesis and Action
Investigation of Gene Polymorphisms Influencing Steroid Synthesis and Action in Patients With Deficient Steroid Biosynthesis and Disorders of Sex Development
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The extend of steroid biosynthesis and action is mainly dependent on underlying genetic polymorphisms and gene mutations. These sequence variations in multiple genes involved in steroid biosynthesis and action cause different diseases (for example congenital adrenal hyperplasia or disorders of sex development). In addition, sequence variations in several other genes may influence the severity of a genetically caused disease of steroid biosynthesis or action. By this, the differences in an observed phenotype may be explained. Within the study all genes necessary for adrenal and gonadal steroid biosynthesis and several genes which are known to influence the action of steroid hormones will be analysed in patients with congenital disorders of adrenal and gonadal steroid biosynthesis, disorders of steroid action and disorders of sex development. The primary aim is to set up a correlation of the disease phenotype with the different genotypes detected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2007
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 8, 2007
CompletedFirst Posted
Study publicly available on registry
June 12, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedSeptember 5, 2013
September 1, 2013
6 years
June 8, 2007
September 4, 2013
Conditions
Study Arms (2)
1
2
Eligibility Criteria
Inclusion Criteria: * Disorders of Sex Development * Congenital Adrenal Hyperplasia * Congenital Adrenal Hypoplasia * Adrenal Insufficiency * Mineralocorticoid Deficiency * Salt-loss
You may qualify if:
- Disorders of Sex Development
- Congenital Adrenal Hyperplasia
- Congenital Adrenal Hypoplasia
- Adrenal Insufficiency
- Mineralocorticoid Deficiency
- Salt-loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Paul-Martin Holterhus, MD
University Hospital Schleswig-Holstein
- PRINCIPAL INVESTIGATOR
Felix G Riepe, MD
University Hospital Schleswig-Holstein
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
June 8, 2007
First Posted
June 12, 2007
Study Start
June 1, 2007
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
September 5, 2013
Record last verified: 2013-09